FAQs

A clinical research study is a medical research study in people. The potential treatment or device being studied only enters a clinical study after researchers test it in the laboratory. If it looks promising, scientists carefully test and collect data about the potential treatment through clinical studies. A clinical study helps us learn how an investigational treatment works in the body. Clinical studies must be reviewed and approved by a regulatory agency to ensure the health, privacy, and safety of study participants. In the United States, it’s the Food and Drug Administration (FDA). In Europe, it’s the European Medicines Agency (EMA). Agencies vary by region. They decide whether to approve the investigational treatment for doctors to prescribe.

The first step is discovering and developing an investigational treatment to study. After that, clinical studies show if it is safe and effective and provide information on any side effects. Sometimes, researchers compare the potential medicine to a placebo. The placebo looks and is administered like the potential treatment but has no active ingredients. The potential treatment may also be compared to a standard treatment that is already approved and used for treatment. They compare it to current treatments, if available, to find out if the potential treatment is better. 

For more information regarding the ILLUMINATE study, visit the About ILLUMINATE section.
About ILLUMINATE

To see if you can join the study, take our questionnaire in the Am I eligible? section.
Am I eligible?

About 99 people with PAH worldwide are expected to participate in the ILLUMINATE study. To find your nearest study site, please visit our Site Finder.
Site finder

You will receive information on what to expect, as well as your role and responsibilities if you join the ILLUMINATE study. You may leave the study at any time without it affecting your regular health care. If you join the study, there are certain things you will be expected to do. This includes attending study visits and undergoing certain assessments and procedures.

Your participation in the ILLUMINATE study may last at least 9 months and up to 2.5 years.

You might benefit from extra health check-ups on top of your regular medical care. You will also help us increase our medical understanding of PAH which may benefit others in the future with this condition.

The Informed Consent Form talks about all known risks. Feel free at any time to let your doctor know if you have any questions, they will be happy to help you.

Clinical studies are 100% voluntary. You can stop at any time.

The study is taking place in multiple countries worldwide. To find a study site near you, visit our Site Finder.
Site finder